We are live on ! Find out more

Phibro Animal Health

PAHC

Market cap $1.58B

38.88 USD

+0.02

0.05%

At close Updated Oct 30, 4:00 PM EDT

1 day

0.05%

5 days

0.21%

1 month

8.79%

3 months

6.67%

6 months

-26.89%

Year to date

4.24%

1 year

-7.12%

5 years

73.26%

10 years

49.83%

About: Phibro Animal Health Corp is a world-wide diversified animal health and mineral nutrition company. It strive to be a trusted partner with livestock producers, farmers, veterinarians and consumers who raise and care for farm and companion animals by providing solutions to help them maintain and enhance the health of their animals. It develop, manufacture and market products for food animals including poultry, beef and dairy cattle, swine, aquaculture and dogs. It has three segments Animal Health, Mineral Nutrition, and Performance Products. Majority of revenue comes from Animal Health segment. Animal health products are anti-bacterials, anticoccidials, nutritional specialty products, and vaccines, and vaccine adjuvants that help improve the animal's health.

Employees: 2,605

Healthcare Drug Manufacturers - Specialty & Generic

News

Positive

Neutral

Negative

Sentiment 3-Months

Positive 55.2%

Neutral 41.4%

Negative 3.4%

Phibro Animal Health Corporation to Host Webcast and Conference Call on First Quarter Results

TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (Nasdaq: PAHC) expects to announce its first quarter financial results on Wednesday, November 4, 2026, after the market closes. Phibro management will host a conference call and webcast on Thursday, November 5, 2026, at 9:00 AM Eastern Time. Interested parties are invited to listen to the conference call and view the presentation slides by visiting https://investors.pahc.com. The discussion will also be available by dialing +1 (83.

Phibro Animal Health Corporation to Host Webcast and Conference Call on First Quarter Results

Zacks Investment Research

Phibro Animal Health (PAHC) Earnings Expected to Grow: Should You Buy?

Phibro (PAHC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Phibro Animal Health (PAHC) Earnings Expected to Grow: Should You Buy?

Zacks Investment Research

Should Value Investors Buy Phibro Animal Health (PAHC) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Should Value Investors Buy Phibro Animal Health (PAHC) Stock?

Zacks Investment Research

Will Phibro (PAHC) Beat Estimates Again in Its Next Earnings Report?

Phibro (PAHC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Will Phibro (PAHC) Beat Estimates Again in Its Next Earnings Report?

Zacks Investment Research

PAHC or SYK: Which Is the Better Value Stock Right Now?

Investors interested in stocks from the Medical - Products sector have probably already heard of Phibro Animal Health (PAHC) and Stryker (SYK). But which of these two stocks presents investors with the better value opportunity right now?

PAHC or SYK: Which Is the Better Value Stock Right Now?

Zacks Investment Research

Is it the Right Time to Add Phibro Stock to Your Portfolio?

PAHC's Animal Health gains from MFA, vaccine and mineral nutrition growth, but tariffs, costs and currency swings remain key risks to its outlook.

Is it the Right Time to Add Phibro Stock to Your Portfolio?

Zacks Investment Research

PAHC vs. HAE: Which Stock Is the Better Value Option?

Investors with an interest in Medical - Products stocks have likely encountered both Phibro Animal Health (PAHC) and Haemonetics (HAE). But which of these two stocks presents investors with the better value opportunity right now?

PAHC vs. HAE: Which Stock Is the Better Value Option?

Zacks Investment Research

Why Is Phibro (PAHC) Down 6.7% Since Last Earnings Report?

Phibro (PAHC) reported earnings 30 days ago. What's next for the stock?

Why Is Phibro (PAHC) Down 6.7% Since Last Earnings Report?

Zacks Investment Research

Best Momentum Stocks to Buy for September 21st

SEI, SDRL and PAHC made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on September 21st, 2026.

Best Momentum Stocks to Buy for September 21st

Zacks Investment Research

PAHC vs. HAE: Which Stock Should Value Investors Buy Now?

Investors interested in stocks from the Medical - Products sector have probably already heard of Phibro Animal Health (PAHC) and Haemonetics (HAE). But which of these two stocks presents investors with the better value opportunity right now?

PAHC vs. HAE: Which Stock Should Value Investors Buy Now?

See News Rankings

Price charts implemented using Lightweight Charts™